ANI Pharmaceuticals Inc

ANIP
66,77
0,77 (1,17%)
Ultimo aggiornamento: 20:47:24
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202422:05GLOBEANI Pharmaceuticals to Discuss First Quarter 2024 Financial..
09/4/202412:50GLOBEANI Pharmaceuticals Announces the Launch of Baclofen Oral..
04/4/202412:50GLOBEANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month..
03/4/202412:50GLOBEANI Pharmaceuticals to Participate at the Piper Sandler..
27/3/202411:50GLOBEANI Pharmaceuticals Announces the Launch of Levofloxacin..
09/3/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:59EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 144 - Report of proposed sale of securities
06/3/202423:58EDGAR2Form 144 - Report of proposed sale of securities
06/3/202423:31EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:29EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:00EDGAR2Form 144 - Report of proposed sale of securities
05/3/202401:18EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202412:58EDGAR2Form 8-K - Current report
29/2/202412:50GLOBEANI Pharmaceuticals Reports Fourth Quarter and Record..
23/2/202422:51EDGAR2Form 8-K - Current report
20/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202412:50GLOBEANI Pharmaceuticals to Present at the Leerink Partners..
16/2/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:00EDGAR2Form 8-K - Current report
07/2/202412:50GLOBEANI Pharmaceuticals to Discuss Fourth Quarter and Full Year..
29/1/202412:50GLOBEANI Pharmaceuticals to Participate at the Guggenheim..
24/1/202400:14EDGAR2Form 144 - Report of proposed sale of securities
23/1/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 65,91 Min: 65,68 Max: 66,91
Chiusura: 66,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network